Piper Sandler Maintains Overweight on Bioage Labs, Lowers Price Target to $40

Benzinga · 2d ago
Piper Sandler analyst Yasmeen Rahimi maintains Bioage Labs (NASDAQ:BIOA) with a Overweight and lowers the price target from $73 to $40.